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Phytochemical Studies on Stemona aphylla: Isolation of a New Stemofoline Alkaloid and Six
New Stemofurans
Thanapat Sastraruji,*,† Sukanda Chaiyong,‡ Araya Jatisatienr,‡ Stephen G. Pyne,† Alison T. Ung,§ and Wilford Lie†
School of Chemistry, UniVersity of Wollongong, Wollongong, New South Wales, 2522, Australia, Department of Chemistry and Forensic
Science, UniVersity of Technology Sydney, Sydney, 2007, Australia, and Department of Biology, Chiang Mai UniVersity,
Chiang Mai 50202, Thailand
ReceiVed September 19, 2010
A new stemofoline alkaloid, (2′S)-hydroxy-(11S,12R)-dihydrostemofoline (3), new stemofurans M-R (8-13), and known
compounds stemofoline (1), (2′S)-hydroxystemofoline (2), stemofuran E (4), stemofuran F (5), stemofuran J (6), and stilbostemin
F (7) have been isolated from the root extracts of Stemona aphylla. The structures and relative configurations of these new
compounds have been determined by spectroscopic data interpretation and from semisynthetic studies. These natural and
semisynthetic alkaloids were tested for acetylcholinesterase inhibitory activities and were found to be 10-20 times less active
than 1′,2′-didehydrostemofoline itself. Stemofurans 4, 6, 8, 11, and 13 were tested for their antibacterial and antifungal activities.
Three of these showed antibacterial activities against MRSA with MIC values of 15.6 µg/mL.
The Stemona family of alkaloids has been structurally classified
by Pilli into eight different groups.1 The pyrrolo[1,2-a]azepine
nucleus is common to all compounds in six of these groups, while
a pyrido[1,2-a]azepine ring system is found in the stemocurtisine
group of Stemona alkaloids.1-10 A miscellaneous group comprising
five Stemona alkaloids has also been identified.1 Greger has
classified the Stemona alkaloids into three skeletal types based on
their proposed biosynthetic origins.2 Recently, a new structural type
of Stemona alkaloid was identified with the isolation of two
alkaloids from Stemona sessilifolia (Miq.) (Stemonaceae) having
an unusual pyrido[1,2-a]azonine nucleus.11 The pure alkaloids
derived from the extracts of the leaves and roots of Stemona species
have insect toxicity, antifeedent and repellent activities,1,4,5,12-14
and antitussive activities.15 The antifungal properties of these
extracts, however, are due to stilbenoid molecules that include
substituted 2-phenylbenzofuran compounds (stemofurans A-K).16
We report here the isolation and structure determination of the novel
stemofoline alkaloid (2′S)-hydroxy-(11S,12R)-dihydrostemofoline
(3), novel 2-phenylbenzofurans, stemofurans M-R (8-13), known
alkaloids (1 and 2), and known stilbenoids (stemofurans E, F, and
J and stilbostemin F) from root extracts of Stemona aphylla. Studies
of the activity of alkaloids 1-3 and two analogues against AChE
and the antibacterial and antifungal activities of five of the
stemofurans are also reported.
Results and Discussion
The roots of S. aphylla were collected in Lampang Province,
Thailand, in April 2009 at a location different from that of our
previous study on this plant species.17 An ethanol extract (100.0
g) of the roots was partitioned between 50% aqueous MeOH and
CH2Cl2 to yield 8.86 g of CH2Cl2 extract. Successive separations
of 4.0 g of the crude material by column chromatography (CC),
and in some cases preparative TLC or LC, gave the known alkaloids
stemofoline (1) (395.0 mg) and (2′S)-hydroxystemofoline (2) (70.0
mg) and the new alkaloid (2′S)-hydroxy-(11S,12R)-dihydrostemo-
foline (3) (14.0 mg). Known phenylbenzofurans, stemofuran E (4)
(13.2 mg), stemofuran F (5) (1.8 mg), and stemofuran J (6) (33.9
mg), the known dihydrostilbene stilbostemin F (7) (0.8 mg), and
six new phenylbenzofurans, stemofuran M (8) (6.4 mg), stemofuran
N (9) (0.9 mg), stemofuran O (10) (0.6 mg), stemofuran P (11)
(5.8 mg), stemofuran Q (12) (2.0 mg), and stemofuran R (13) (12.8
mg), were also isolated (Figure 1). The two known alkaloids and
the four known stilbenoids were identified by comparison of their
spectroscopic/spectrometric data (NMR and MS) with those
reported.12,18,19
The HRESIMS (m/z 406.2216 [MH]+, calcd 406.2230) of 3
showed that it had the molecular formula C22H32NO6, consistent
with a dihydro derivative of 2. The 1H and 13C NMR spectra of 3
indicated the presence of the polycyclic ring system of stemofoline
(1)11,16 and an OH group at C-2′ similar to that of (2′S)-
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hydroxystemofoline (2).11 However, comparison of the 13C/DEPT
NMR spectra of 3 with that of 2 showed that C-11 and C-12 in 3
were methine carbons rather than quaternary carbons as seen in 2.
The 1H NMR spectrum of 3 showed two mutually coupled methine
proton signals at δ 3.78 (dd, J10,11 ) 9.0 Hz, J11,12 ) 2.5 Hz, H-11)
and δ 4.58 (br s, W1/2 ) 2.5 Hz, H-12), which also indicated that
compound 3 was an 11,12-dihydrostemofoline. NOESY experi-
ments showed a significant cross-peak between the C-10 methyl
protons (H-17) and H-11, indicating their syn stereochemical
relationship. Thus, assuming that 3 had the same absolute config-
uration as stemofoline (1) in rings A-C, we assigned the 11S
configuration to compound 3. This configuration was later confirmed
by semisynthesis of 3 from 2 in two steps. NMR experiments on
3, however, did not permit assignment of the configuration at C-12.
In 2004, Mungkornasawakul14 reported the isolation of (11S,12R)-
dihydrostemofoline from Stemona burkillii Prain and the semisyn-
thesis of (11S,12S)-dihydrostemofoline by hydrogenation of ste-
mofoline (1). The 1H and 13C NMR spectra of these compounds
were similar but not identical. Indeed, there was a significant
difference in the chemical shifts and coupling constants for the
signals of H-11 and H-12 in the 1H NMR spectra of these two
compounds, especially J11,12, which was 3 Hz in (11S,12R)-
dihydrostemofoline and 7 Hz in (11S,12S)-dihydrostemofoline. On
the basis of these differences we assigned the 12R configuration to
3. The 2′S configuration of 3 was determined by its semisynthesis
from 2, as outlined in Scheme 1. The Z to E isomerization of
compound 2 by exposure to irradiation from a 500 W sun lamp for
4 h in chloroform solution and acetophenone gave a 1:1 mixture
of 2 and 14, which were separated by CC in yields of 47% and
44%, respectively (Scheme 1). Hydrogenation of 2 over Pd/C in
EtOAc provided the (11S,12S)-dihydrostemofoline derivative 15
(d, J11,12 ) 6.5 Hz), while that of 14 gave the natural product 3
(Scheme 2). On the basis of a comparison of the 1H and 13C NMR
chemical shifts with those of the synthesized compounds, alkaloid
3 was assigned as (2′S)-hydroxy-(11S,12R)-dihydrostemofoline. The
complete 1H and 13C NMR assignments for 3 and 15 based on
extensive COSY, NOESY, HSQC, and HMBC experiments are
shown in Table S2-S4 of the Supporting Information.
The benzofurans 8-13 were characterized by two independent
aromatic systems separated by the furan ring of the benzofuran
moiety. The connectivities of the directly coupled protons were
determined using H/H-COSY experiments, and the positions of
methyl and methoxy groups in ring A or methyl and methoxy
groups in ring B were elucidated by NOESY experiments (sum-
marized in Table S1, Supporting Information). HSQC and HMBC
experiments confirmed the assignments of the structures and allowed
assignment of the quaternary carbon atoms in the 13C NMR spectra
(see Supporting Information). The molecular formulas of com-
pounds 8-13 were determined by HRESIMS.
Compound 8 had the molecular formula C17H16O5. The 1H NMR
spectrum showed resonances for three benzofuran protons at δ 7.01
(s, 1H, H-1′′), 6.69 (br s, 1H, H-5), and 6.35 (d, J ) 1.5 Hz, 1H,
H-3), an OH at δ 8.73 (br s, 1H, 2-OH), and a methoxy group at
δ 3.82 (s, 3H, 4-O-CH3). The meta-like coupling between the
aromatic protons H-3 and H-5 and the NOESY correlations between
both of these aromatic proton resonances and the C-4 methoxy
group confirmed the benzofuran moiety. The substituted phenyl
group of 8 showed two aromatic proton signals [δ 6.88 (d, J ) 2.5
Hz, 1H, H-6′) and 6.53 (d, J ) 2.5 Hz, 1H, H-4′)], an aromatic
methyl resonance at δ 2.35 (s, 3H, 2′-CH3), an OH resonance at δ
8.73 (br s, 1H, 3′-OH), and an OCH3 signal at δ 3.79 (s, 3H, 5′-
OCH3). The meta-like coupling between the aromatic protons H-4′
and H-6′ and the NOESY correlations between both of these
aromatic resonances and the C-5′ OCH3 group and between H-1′′
and the C-2′ methyl substituent confirmed the structural assignment
of the substituted phenyl moiety.
Compound 9 had the molecular formula C17H16O5. The 1H NMR
spectrum showed resonances for three benzofuran protons, an OH,
and an OCH3. This NMR pattern indicated compounds 8 and 9
had the same benzofuran ring structures. The substituted phenyl
group of 9 showed three singlet aromatic proton signals [δ 7.01 (s,
2H, 2′-H and 6′-H) and 6.67 (s, 1H, 4′-H)] and a signal for two
OCH3 groups at δ 3.87 (3′ and 5′). The NOESY correlations
between H-1′′ and both H-2′ and H-6′ indicated that the latter two
protons occupied ortho positions relative to the benzofuran sub-
stituent on the phenyl ring.
The NMR spectra of compound 10 (C19H20O4) indicated that
compounds 6 and 10 had the same benzofuran ring structures. The
fully substituted symmetrical phenyl group of 10 showed aromatic
methyl group signals at δ 2.27 (s, 3H, 4′-CH3) and 2.10 (s, 6H,
2′-CH3 and 6′-CH3) and resonances for two identical OCH3 groups
at δ 3.72 (3′ and 5′). The NOESY correlation between H-1′′ and
the two identical methyl groups at δ 2.10 indicated that they were
at C-2′ and C-6′. The OCH3 groups were at C-3′ and C-5′, evident
from NOESY correlations to the C-2′, C-4′, and C-6′ methyl groups.
The HRESIMS of compound 11 indicated a molecular formula
of C18H18O5. The 1H NMR spectrum showed resonances for three
benzofuran protons, an OH at δ 8.98 (br s, 1H, 2-OH), and an
OCH3 at δ 3.82 (s, 3H, 4-O-CH3). This NMR pattern indicated
Figure 1. New stemofurans 8-13 (compound numbering is based
on that proposed by Greger16).
Scheme 1
Scheme 2
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that compounds 8, 9, and 11 had the same benzofuran ring
structures. The substituted phenyl group of 11 showed aromatic
proton signals at δ 6.92 (d, J ) 2.0 Hz, 1H, H-6′) and 6.49 (d, J
) 2.0 Hz, 1H, H-4′), an aromatic methyl resonance at δ 2.31 (s,
3H, 2′-CH3), and two OCH3 signals at δ 3.87 (3′) and 3.84 (5′).
NOESY correlations between 2′-CH3 and both H-1′′ and the 3′-
OCH3 indicated that compound 11 was the C-2′ methyl analogue
of compound 9.
Compound 12 had the molecular formula C18H18O5. The 1H NMR
spectrum showed benzofuran protons at δ 7.13 (s, 1H, H-1′′) and
6.76 (s, 1H, H-5), an OH resonance at δ 8.47 (br s, 1H, 2-OH), a
methyl resonance at δ 2.15 (s, 3H, 3-CH3), and a methoxy signal
at δ 3.89 (s, 3H, 4-OCH3). The NOESY correlations for the
benzofuran ring between the 3-CH3 and both the 2-OH and 4-O-
CH3 indicated that compound 12 was the C-3 methyl analogue of
compound 8. The substituted phenyl group of 12 showed aromatic
proton signals at δ 6.89 (d, J ) 2.5 Hz, 1H, H-6′) and 6.52 (d, J
) 2.5 Hz, 1H, H-4′), an aromatic methyl resonance at δ 2.34 (s,
3H, 2′-CH3), a hydroxyl resonance at δ 8.47 (br s, 1H, 3′-OH),
and a methoxy signal at δ 3.79 (s, 3H, 5′-OCH3). This NMR pattern
indicated that compounds 8 and 12 had the same phenyl ring
structures.
Compound 13 had the molecular formula C19H20O5. The 1H NMR
spectrum showed resonances for three benzofuran protons [δ 7.02
(s, H-1′′), 6.70 (br s, H-5), and 6.36 (br s, H-3)], an OH at δ 8.95
(br s, 2-OH), and a methoxy group at δ 3.82 (s, 3H, 4-O-CH3).
This NMR pattern indicated that compounds 8, 9, 11, and 13 had
the same benzofuran ring structures. The substituted phenyl group
of 13 showed a singlet aromatic proton signal at δ 7.16 (H-6′),
two aromatic methyl resonances at δ 2.41 (s, 2′-CH3) and 2.16 (s,
4′-CH3), and methoxy signals at δ 3.90 (s, 5′-OCH3) and 3.72 (s,
3′-OCH3). This NMR pattern indicated that compounds 6 and 13
had the same phenyl ring structures.
Insecticidal activity shown by root extracts of Stemona plants
has been closely associated with the acetylcholinesterase (AChE)
inhibitory activities of their alkaloid components.2,3,14,20 Com-
pounds 1-3, 14, and 15 were therefore screened by TLC bioau-
tography for their AChE inhibitory activities using the method of
Hostettmann et al.21 and galanthamine and 1,′2′-didehydrostemo-
foline as positive controls. The results are shown in Table 1.
In our earlier studies on the AChE inhibitory activities of several
pyrrolo[1,2-a]azepine Stemona alkaloids and their analogues we
found that 1′,2′-didehydrostemofoline and (1′R)-hydroxystemofoline
were the most active compounds, with minimum inhibitory
concentrations of 5 ng.22 These compounds, however, were not as
active as the positive control galanthamine (minimum inhibitory
concentration of 1 ng). Compounds 1, 2, and 14 were the most
active among the five compounds tested, with a MIC of 10 ng,
while compounds 3 and 15 were significantly less active, with a
MIC of 50 and 100 ng, respectively, perhaps due to the lack of
rigidity of the C-11-C-12 double bond.
Antimicrobial activities of compounds 4, 6, 8, 11, and 13 against
the Gram-negative bacteria Escherichia coli and Klebsiella pneu-
moniae and the Gram-positive bacteria Staphylococcus aureus,
methicillin-resistant Staphylococcus aureus (MRSA), and Strepto-
coccus pyogenes and the antifungal activities against Candida
albicans and Cryptococcus neoformans were determined.23 Two
antibiotic agents, gentamycin and amphotericin B, were used as
the positive controls for the antibacterial activity and antifungal
activity, respectively. The antimicrobial activities are shown in
Table 2. Antibacterial activities of the tested compounds were
generally weak to poor against the Gram-negative bacteria.
Compounds 8, 11, and 13 showed modest activities against S.
aureaus. All compounds were less active than the positive control
gentamycin, except for compounds 4, 6, and 13 against MRSA,
which all had MICs of 15.6 µg/mL, which was significantly less
than that of the control (MIC 45.0 µg/mL). Structurally these three
compounds all have a 2′,3′,4′,5′-tetrasubstituted B ring, which is
the same as that in compounds 6 and 13. Compound 4 has a 3′-
hydroxy group rather than a 3′-methoxy group as found in
compounds 6 and 13. While the testing of a larger number of
benzofuran compounds of a greater structural diversity would be
required for sound structure-activity conclusions to be drawn,
nevertheless, it appears that the substitution pattern on the B ring
is important for antibacterial activity against MRSA. The antifungal
activities of benzofurans 11 and 13 against C. albicans were the
same as the positive control amphotericin B, while compounds 4,
6, and 8 had slightly weaker activities (Table 2). All benzofuran
compounds were less active than the positive control against C.
neoformans. Compounds 4, 6, and 11 showed good activities with
MIC values of 7.8 µg/mL, while compounds 8 and 13 were less
active. The antifungal activities of 4 and 6 were consistent with
that of a previous study, showing that 4 had strong activity against
C. herbarum and 6 had strong activity against P. grisea.16
Experimental Section
General Experimental Procedures. 1H (500 MHz), 13C (125 MHz),
and 2D NMR spectra were recorded on a Varian Unity 500 spectrom-
eter. High-resolution ESIMS were obtained with a Micromass QTOF
2 mass spectrometer using a cone voltage of 30 V and polyethyleneg-
lycol as an internal reference. TLC analysis were performed on
aluminum-backed Merck 60 GF254 silica gel, and bands were detected
by UV light (λ 254 nm) or stained with Dragendorff’s reagent. Column
chromatography (CC) was performed using Merck GF254 flash silica
gel (40-63 µm). Preparative TLC was performed using Merck TLC
silica gel 60 F254 (20 × 20 cm). Preparative-LC analysis was performed
using a Waters PrepLC system (Waters Corporation, Milford, MA,
USA) equipped with a Waters Prep degasser and a Waters 2489 UV/
visible detector. Separation was performed on a Phenomenex Gemini
C18 column (110 Å, 21.2 × 150 mm, 5 µm) with a sample injection
volume of 10 mL. Solvent A (H2O containing 0.1% formic acid) and
solvent B (acetonitrile containing 0.1% formic acid) were used as mobile
phases. Isocratic elution was performed using 40% B at a flow rate of
24.0 mL/min.
Plant Material. Roots of S. aphylla were collected in Lampang
Province, Thailand, in April 2009. A voucher specimen (number 09-
111) was deposited at the herbarium of the Department of Biology,
Chiang Mai University. Plant material was identified by Mr. James F.
Maxwell from the Department of Biology, Chiang Mai University.
Extraction and Isolation. The ground root, dried in an oven at 50
°C, of Stemona aphylla (15.14 kg) was extracted with 95% EtOH (4
× 10 L) for 16 days (4 days for each extraction) at rt. The extract was
evaporated to give a dark residue (1.45 kg). A portion of the residue
(100.0 g) was partitioned between 200 mL of 50% aqueous MeOH
and 200 mL of CH2Cl2 (3 times) to yield 8.86 g of crude CH2Cl2 extract.
A portion of the CH2Cl2 extract (4.00 g) was separated by CC on
flash silica gel (400 g) using gradient elution from 100% CH2Cl2 to
20% MeOH/CH2Cl2 to give 13 fractions. Fraction 10 (1.799 g) was
purified by CC using MeOH/CH2Cl2 (0:100 to 20:80, v/v) to yield seven
fractions (fractions 10.1-10.7). Further separations of fraction 10.4
(998.0 mg) by CC, and in some cases preparative LC using isocratic
elution with 40% MeCN/water containing 0.1% formic acid, gave
stemofuran E (4) (13.2 mg), stemofuran F (5) (1.8 mg), stemofuran J
(6) (15.5 mg), stilbostemin F (7) (0.8 mg), stemofuran M (8) (6.4 mg),
stemofuran N (9) (0.9 mg), stemofuran O (10) (0.6 mg), stemofuran P
(11) (5.8 mg), stemofuran Q (12) (2.0 mg), and stemofuran R (13)
(12.8 mg). Compounds 10 and 12 could not be isolated in pure form,
Table 1. Minimum Amount of Sample Found to Inhibit AChE
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even after HPLC. Fraction 10.6 (917.0 mg) was purified by CC with
gradient elution using MeOH/CH2Cl2 (0:100 to 20:80, v/v) to afforded
stemofoline (1) (395.0 mg), (2′S)-hydroxystemofoline (2) (70.0 mg),
and (2′S)-hydroxy-(11S,12R)-dihydrostemofoline (3) (14.0 mg). Tables
of the NMR data of all compounds are in the Supporting Information.
(2′S)-Hydroxy-(11S,12R)-dihydrostemofoline (3): pale yellow gum;
[R]D25 +49 (c 0.2, CHCl3); 1H NMR δ 4.52 (br s, 1H, H-12), 4.24 (br
s, 1H, H-2), 4.05 (s, 3H, O-CH3), 3.72 (dd, J ) 9.0, 2.5 Hz, 1H, H-11),
3.52 (dt, J ) 10.5, 6.0 Hz, 1H, H-2′), 3.35 (br s, 1H, H-9a), 3.12 (ddd,
J ) 14.0, 10.5, 5.5 Hz, 1H, H-5a), 2.89 (ddd, J ) 13.5, 8.5, 4.5 Hz,
1H, H-5b), 2.60-2.52 (m, 1H, H-10), 2.33 (d, J ) 6.0 Hz, 1H, H-7),
2.01 (d, J ) 12.5 Hz, 1H, H-1a), 1.94 (s, 3H, H-16), 1.86-1.79 (m,
1H, H-6a), 1.69-1.62 (m, 1H, H-6b), 1.63 (d, J ) 12.5 Hz, 1H, H-1b),
1.59 (d, J ) 14.0 Hz, 1H, H-1′a), 1.55 (dd, J ) 11.0, 3.5 Hz, 1H,
H-9), 1.49 (dd, J ) 14.5, 10.5 Hz, 1H, H-1′b), 1.43 (quin, J ) 7.0 Hz,
1H, H-3′a), 1.32 (quin, J ) 7.0 Hz, 1H, H-3′b), 1.02 (d, J ) 6.5 Hz,
3H, H-17), 0.85 (t, J ) 7.5 Hz, 3H, H-4′); 13C NMR δ 174.7 (C-15),
170.4 (C-13), 111.6 (C-8), 98.7 (C-14), 86.1 (C-11), 82.3 (C-3), 78.7
(C-2), 76.3 (C-12), 71.3 (C-2′), 61.0 (C-9a), 59.1 (OCH3), 52.4 (C-7),
47.6 (C-9), 47.1 (C-5), 36.2 (C-1′), 34.1 (C-1), 33.2 (C-10), 30.7 (C-
3′), 27.0 (C-6), 14.9 (C-17), 9.9 (C-4′), 8.8 (C-16); HRESIMS m/z
406.2216 [MH]+, calcd for C22H32NO6 406.2230.
Stemofuran M (8): brown, amorphous solid; 1H NMR δ 8.73 (br
s, 1H, 2-OH), 8.73 (br s, 1H, 3′-OH), 7.01 (s, 1H, H-1′′), 6.88 (d, J
) 2.5 Hz, 1H, H-6′), 6.69 (br s, 1H, H-5), 6.53 (d, J ) 2.5 Hz, 1H,
H-4′), 6.35 (d, J ) 1.5 Hz, 1H, H-3), 3.82 (s, 3H, 4-OCH3), 3.79 (s,
3H, 5′-OCH3), 2.35 (s, 3H, 2′-CH3); 13C NMR δ 160.4 (C-4), 159.0
(C-6), 157.4 (C-3′), 157.4 (C-5′), 153.9 (C-2′′), 152.0 (C-2), 132.7 (C-
1′), 115.2 (C-2′), 113.2 (C-1), 104.8 (C-6′), 103.6 (C-1′′), 102.3 (C-
4′), 98.2 (C-3), 88.3 (C-5), 55.9 (4-OCH3), 55.5 (5′-OCH3), 13.1 (2′-
CH3); HRESIMS m/z 301.1059 [MH]+, calcd for C17H17O5 301.1076.
Stemofuran N (9): dark brown gum; 1H NMR δ 8.96 (br s, 1H,
2-OH), 7.25 (s, 1H, H-1′′), 7.01 (s, 1H, H-2′), 7.01 (s, 1H, H-6′), 6.69
(br s, 1H, H-5), 6.67 (s, 1H, H-4′), 6.35 (d, J ) 1.5 Hz, 1H, H-3), 3.87
(s, 3H, 3′-OCH3), 3.87 (s, 3H, 5′-OCH3), 3.82 (s, 3H, 4-OCH3); 13C
NMR δ 162.3 (C-3′), 162.3 (C-5′), 160.6 (C-4), 158.0 (C-6), 153.9
(C-2′′), 152.1 (C-2), 133.4 (C-1′), 113.3 (C-1), 102.9 (C-6′), 102.9 (C-
2′), 101.0 (C-4′), 100.5 (C-1′′), 98.4 (C-3), 88.5 (C-5), 56.0 (4-O-CH3),
55.8 (3′-OCH3), 55.8 (5′-OCH3); HRESIMS m/z 301.1056 [MH]+, calcd
for C17H17O5 301.1076.
Stemofuran O (10): brown gum; 1H NMR δ 8.83 (br s, 1H, 2-OH),
7.13 (dd, J ) 8.0, 8.0 Hz, 1H, H-4), 7.03 (d, J ) 8.0 Hz, 1H, H-5),
6.83 (d, J ) 1.0 Hz, 1H, H-1′′), 6.72 (d, J ) 8.0 Hz, 1H, H-3), 3.72 (s,
3H, 3′-O-CH3), 3.72 (s, 3H, 5′-OCH3), 2.27 (s, 3H, 4′-CH3), 2.10 (s,
3H, 2′-CH3), 2.10 (s, 3H, 6′-CH3); 13C NMR δ 157.3 (C-2′′), 156.6
(C-3′), 156.6 (C-5′), 153.4 (C-6), 152.0 (C-2), 131.1 (C-1′), 127.8 (C-
4′), 126.4 (C-2′), 126.4 (C-6′), 125.7 (C-4), 119.3 (C-1), 108.7 (C-3),
104.4 (C-1′′), 103.6 (C-5), 60.2 (3′-OCH3), 60.2 (5′-OCH3), 13.8 (2′-
CH3), 13.8 (6′-CH3), 10.0 (4′-CH3); HRESIMS m/z 313.1422 [MH]+,
calcd for C19H21O4 313.1440.
Stemofuran P (11): brown gum; 1H NMR δ 8.98 (br s, 1H, 2-OH),
7.01 (s, 1H, H-1′′), 6.92 (d, J ) 2.0 Hz, 1H, H-6′), 6.69 (br s, 1H,
H-5), 6.58 (d, J ) 2.0 Hz, 1H, H-4′), 6.35 (d, J ) 1.5 Hz, 1H, H-3),
3.87 (s, 3H, 3′-OCH3), 3.84 (s, 3H, 5′-O-CH3), 3.82 (s, 3H, 4-O-CH3),
2.31 (s, 3H, 2′-CH3); 13C NMR δ 160.5 (C-4), 159.9 (C-3′), 159.6 (C-
5′), 157.5 (C-6), 153.7 (C-2′′), 152.1 (C-2), 132.4 (C-1′), 116.9 (C-2′),
113.2 (C-1), 104.7 (C-6′), 104.0 (C-1′′), 99.2 (C-4′), 98.3 (C-3), 88.3
(C-5), 56.2 (3′-OCH3), 56.0 (4-OCH3), 55.7 (5′-OCH3), 13.1 (2′-CH3);
HRESIMS m/z 315.1217 [MH]+, calcd for C18H19O5 315.1232.
Stemofuran Q (12): black, amorphous solid; 1H NMR δ 8.47 (br s,
1H, 2-OH), 8.47 (br s, 1H, 3′-OH), 7.13 (s, 1H, H-1′′), 6.89 (d, J )
2.5 Hz, 1H, H-6′), 6.76 (s, 1H, H-5), 6.52 (d, J ) 2.5 Hz, 1H, H-4′),
3.89 (s, 3H, 4-O-CH3), 3.79 (s, 3H, 5′-O-CH3), 2.34 (s, 3H, 2′-CH3),
2.15 (s, 3H, 3-CH3); 13C NMR δ 159.2 (C-5′), 158.5 (C-4), 157.4 (C-
3′), 154.9 (C-2′′), 153.4 (C-6), 148.8 (C-2), 132.9 (C-1′), 115.0 (C-2′),
112.9 (C-1), 107.4 (C-3), 104.7 (C-6′), 103.7 (C-1′′), 102.2 (C-4′), 87.1
(C-5), 56.2 (4-O-CH3), 55.4 (5′-OCH3), 13.2 (2′-CH3), 8.7 (3-CH3);
HRESIMS m/z 315.1237 [MH]+, calcd for C18H19O5 315.1232.
Stemofuran R (13): dark brown, amorphous solid; 1H NMR δ 8.95
(br s, 1H, 2-OH), 7.16 (s, 1H, H-6′), 7.02 (s, 1H, H-1′′), 6.70 (br s,
1H, H-5), 6.36 (br s, 1H, H-3), 3.90 (s, 3H, 5′-OCH3), 3.82 (s, 3H,
4-O-CH3), 3.72 (s, 3H, 3′-O-CH3), 2.41 (s, 3H, 2′-CH3), 2.16 (s, 3H,
4′-CH3); 13C NMR δ 160.4 (C-4), 158.9 (C-3′), 157.5 (C-5′), 157.4
(C-6), 153.8 (C-2′′), 152.0 (C-2), 129.8 (C-1′), 121.4 (C-4′), 120.3 (C-
2′), 113.3 (C-1), 106.1 (C-6′), 103.4 (C-1′′), 98.2 (C-3), 88.3 (C-5),
60.4 (3′-O-CH3), 56.0 (4-O-CH3), 13.9 (2′-CH3), 9.5 (4′-CH3); HRES-
IMS m/z 329.1354 [MH]+, calcd for C19H21O5 329.1389.
Photoisomerization of (2′S)-Hydroxystemofoline (2). To a solution
of 2 (21.2 mg, 0.053 mmol) in CHCl3 (2 mL) was added acetophenone
(20 µL). The mixture was prepared in a NMR tube and exposed to
irradiation from a 500 W sun lamp for 4 h. The solvent was removed
under vacuum to give a mixture (1:1) of 2 and 14 (19.2 mg, 90.6%
yield) as a pale yellow gum. The crude product was purified by
preparative TLC using EtOAc/MeOH (10:90) to give 2 (9.9 mg, 46.7%
yield) as a pale yellow gum and 14 (9.3 mg, 43.9% yield) as a pale
yellow gum.
(11E)-(2′S)-Hydroxystemofoline (14): pale yellow gum; [R]D25 +105
(c 0.3, CHCl3); 1H NMR δ 4.37 (br s, 1H, H-2), 4.11 (s, 3H, OCH3),
3.62 (dt, J ) 9.0, 6.5 Hz, 1H, H-2′), 3.55 (br s, 1H, H-9a), 3.25 (ddd,
J ) 14.5, 9.5, 5.0 Hz, 1H, H-5a), 3.03 (ddd, J ) 13.5, 9.0, 4.5 Hz, 1H,
H-5b), 3.24-3.18 (m, 1H, H-10), 2.64 (d, J ) 6.0 Hz, 1H, H-7), 2.07
(d, J ) 13.0 Hz, 1H, H-1a), 2.04 (s, 3H, H-16), 2.02-1.96 (m, 1H,
H-6a), 1.90-1.84 (m, 1H, H-6b), 1.83 (d, J ) 12.5 Hz, 1H, H-1b),
1.74 (dd, J ) 11.5, 3.0 Hz, 1H, H-9), 1.71 (d, J ) 15.0 Hz, 1H, H-1′a),
1.66 (dd, J ) 14.5, 10.0 Hz, 1H, H-1′b), 1.52 (quin, J ) 7.0 Hz, 1H,
H-3′a), 1.42 (quin, J ) 7.0 Hz, 1H, H-3′b), 1.46 (d, J ) 6.5 Hz, 3H,
H-17), 0.95 (t, J ) 7.5 Hz, 3H, H-4′); 13C NMR δ 170.5 (C-15), 163.3
(C-13), 149.4 (C-11), 129.0 (C-12), 113.0 (C-8), 98.6 (C-14), 82.8 (C-
3), 79.0 (C-2), 71.1 (C-2′), 60.8 (C-9a), 59.5 (O-CH3), 51.9 (C-7), 46.0
(C-9), 47.1 (C-5), 36.2 (C-10), 36.2 (C-1′), 33.5 (C-1), 30.5 (C-3′),
26.7 (C-6), 16.2 (C-17), 9.8 (C-4′), 8.8 (C-16); HRESIMS m/z 404.2086
[MH]+, calcd for C22H30NO6 404.2073.
Hydrogenation of 2. To a solution of 2 (8.4 mg, 0.021 mmol) in
EtOAc (1 mL) was added Pd/C (ca. 5 mg). The mixture was left to stir
under a hydrogen atmosphere (balloon) overnight at rt, when complete
reaction was shown by TLC analysis. The mixture was filtered through
Celite and evaporated under reduced pressure, and the crude product
was purified by preparative TLC using MeOH/CH2Cl2 (5:95) to give
15 (4.3 mg, 51.2% yield) as a pale yellow gum.
(2′S)-Hydroxy-(11S,12S)-dihydrostemofoline (15): colorless gum;
[R]D25 +49 (c 0.3, CHCl3); 1H NMR δ 4.67 (br s, 1H, H-12), 4.25 (br
s, 1H, H-2), 4.03 (s, 3H, O-CH3), 3.65 (t, J ) 7.0 Hz, 1H, H-11), 3.54
(dt, J ) 9.0, 6.5 Hz, 1H, H-2′), 3.38 (br s, 1H, H-9a), 3.13 (ddd, J )
14.5, 9.5, 5.0 Hz, 1H, H-5a), 2.91 (ddd, J ) 13.0, 8.5, 4.5 Hz, 1H,
H-5b), 2.49-2.41 (m, 1H, H-10), 2.36 (d, J ) 6.0 Hz, 1H, H-7), 1.98
(d, J ) 12.0 Hz, 1H, H-1a), 1.89 (s, 3H, H-16), 1.88-1.81 (m, 1H,
H-6a), 1.73-1.66 (m, 1H, H-6b), 1.67 (d, J ) 12.0 Hz, 1H, H-1b),
1.60 (d, J ) 14.5 Hz, 1H, H-1′a), 1.55 (d, J ) 11.5 Hz, 1H, H-9), 1.52
(d, J ) 10.5 Hz, 1H, H-1′b), 1.44 (quin, J ) 7.0 Hz, 1H, H-3′a), 1.34
(quin, J ) 6.5 Hz, 1H, H-3′b), 1.05 (d, J ) 6.5 Hz, 3H, H-17), 0.86 (t,
J ) 7.5 Hz, 3H, H-4′); 13C NMR δ 174.3 (C-15), 172.9 (C-13), 112.3
(C-8), 98.9 (C-14), 87.8 (C-11), 82.3 (C-3), 78.9 (C-2), 78.6 (C-12),
71.2 (C-2′), 61.0 (C-9a), 59.3 (OCH3), 52.4 (C-7), 47.3 (C-9), 47.1
(C-5), 36.2 (C-1′), 34.9 (C-10), 34.0 (C-1), 30.6 (C-3′), 26.8 (C-6),
16.5 (C-17), 9.8 (C-4′), 8.4 (C-16); HRESIMS m/z 406.2237 [MH]+,
calcd for C22H32NO6 406.2230.
Table 2. Antibacterial and Antifungal Activities (MIC in µg/mL)
Gram-negative bacteria Gram-positive bacteria fungi
compound E. coli K. pneumoniae S. aureus MRSA S. pyogenes C. albicans C. neoformans
4 62.5 62.5 62.5 15.6 31.3 7.8
6 62.5 62.5 62.5 15.6 62.5 31.3 7.8
8 125.0 62.5 31.3 31.3 62.5 31.3 31.3
11 62.5 125.0 31.3 62.5 15.6 7.8
13 62.5 62.5 31.3 15.6 15.6 15.6
gentamycin 11.3 11.3 22.5 45.0 5.6
amphotericin B 15.6 3.9
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Hydrogenation of 14. To a solution of 14 (9.3 mg, 0.021 mmol) in
EtOAc (1 mL) was added Pd/C (ca. 5 mg). The mixture was left to stir
under a hydrogen atmosphere (balloon) overnight at rt when complete
reaction was shown by TLC analysis. The mixture was filtered through
Celite and evaporated under reduced pressure, and the crude product
was purified by preparative TLC using MeOH/CH2Cl2 (5:95) to give 3
(2.7 mg, 29.0% yield) as a pale yellow gum.
(2′S)-Hydroxy-(11S,12R)-dihydrostemofoline (3): pale yellow gum;
[R]D25 +51 (c 0.2, CHCl3); 1H NMR δ 4.52 (br s, 1H, H-12), 4.24 (br
s, 1H, H-2), 4.05 (s, 3H, O-CH3), 3.72 (dd, J ) 9.0, 2.5 Hz, 1H, H-11),
3.52 (dt, J ) 10.0, 6.0 Hz, 1H, H-2′), 3.36 (br s, 1H, H-9a), 3.12 (ddd,
J ) 14.5, 10.5, 5.0 Hz, 1H, H-5a), 2.89 (ddd, J ) 13.5, 8.5, 5.0 Hz,
1H, H-5b), 2.60-2.52 (m, 1H, H-10), 2.33 (d, J ) 6.5 Hz, 1H, H-7),
2.01 (d, J ) 12.0 Hz, 1H, H-1a), 1.94 (s, 3H, H-16), 1.86-1.79 (m,
1H, H-6a), 1.69-1.62 (m, 1H, H-6b), 1.63 (d, J ) 11.5 Hz, 1H, H-1b),
1.59 (d, J ) 14.5 Hz, 1H, H-1′a), 1.55 (dd, J ) 11.0, 3.0 Hz, 1H,
H-9), 1.49 (dd, J ) 14.5, 10.5 Hz, 1H, H-1′b), 1.43 (quin, J ) 7.0 Hz,
1H, H-3′a), 1.32 (quin, J ) 7.0 Hz, 1H, H-3′b), 1.03 (d, J ) 6.5 Hz,
3H, H-17), 0.85 (t, J ) 7.5 Hz, 3H, H-4′); 13C NMR δ 174.7 (C-15),
170.4 (C-13), 111.5 (C-8), 98.7 (C-14), 86.1 (C-11), 82.2 (C-3), 78.6
(C-2), 76.3 (C-12), 71.3 (C-2′), 60.9 (C-9a), 59.1 (O-CH3), 52.4 (C-
7), 47.5 (C-9), 47.1 (C-5), 36.1 (C-1′), 34.1 (C-1), 33.1 (C-10), 30.6
(C-3′), 26.9 (C-6), 14.9 (C-17), 9.8 (C-4′), 8.8 (C-16); HRESIMS m/z
406.2216 [MH]+, calcd for C22H32NO6 406.2230.
Bioautography Procedure. TLC bioautography was performed
using the method described by Hostettmann et al.21 and according to
our previous publication.22
Antimicrobial Activity Procedure. Studies of antimicrobial activi-
ties of compounds 4, 6, 8, 11, and 13 against Escherichia coli, Klebsiella
pneumoniae, Staphylococcus aureus, methicillin-resistant Staphylococ-
cus aureus (MRSA), Streptococcus pyogenes, Candida albicans, and
Cryptococcus neoformans were carried out by the broth dilution
method.23 Antibiotics gentamicin and amphotericin B were used as
positive controls.
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